1. Analyst View
2. Research Methodology
3. Regenerative Medicine: Introduction
3.1 Tissue Engineering
3.2 Stem Cell Therapy
4. Industry Characteristics
4.1 R&D: Huge Investments Leading to Product Innovations
4.2 Companies Garnering Success through Collaborations
4.3 Presence of Cut Throat Competition Intensifying Private Sector Participation
4.4 Aging Population Worldwide to Boost Industry
5. Industry Performance
5.1 Current Market Overview and Future Outlook to 2014
5.2 Key Industry Segments
5.2.1 Tissue Engineered Products
5.2.2 Cell Therapy Market
6. Application Areas for Regenerative Medicine
6.1 Cardiovascular Diseases
6.2 Diabetes
6.3 Cancer
6.4 CNS Diseases
6.5 Eye Diseases
7. Key Geographical Market
7.1 US
7.2 Europe
7.3 Asia-Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
8. Pipeline Analysis
9. Competitive Assessment
9.1 Aastrom Biosciences, Inc.
9.2 Advanced Cell Technology, Inc.
9.3 Athersys, Inc
9.4 Amgen, Inc.
9.5 Bioheart, Inc.
9.6 Cytori Therapeutics, Inc.
9.7 Celgene Corporation
9.8 Geron Corporation
9.9 Genzyme Corporation
9.10 Osiris Therapeutics
9.11 Japan Tissue Engineering, Co., Ltd.
9.12 ThermoGenesis Corporation
